Physician profile
Abdul S Khan
NPI 1528028578
$11,302.65
in general payments reported to CMS, 2019-2025
53 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $601 · 2021: $1,525 · 2022: $1,785 · 2023: $2,530 · 2024: $2,543 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,645 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,645.45 |
| Education | $119.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,795.18 | 2021-2025 | |
| Pfizer INC. | $982.87 | 2021-2025 | |
| Ucb, INC. | $957.00 | 2019-2025 | Nayzilam, Rystiggo, Briviact |
| Teva Pharmaceuticals USA, INC. | $643.17 | 2019-2025 | Austedo Xr, Austedo Xr |
| Neurocrine Biosciences, INC. | $476.11 | 2019-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $449.10 | 2019-2024 | Amyvid, Emgality, Kisunla |
| Sk Life Science, INC. | $420.29 | 2021-2025 | |
| Eisai INC. | $332.94 | 2021-2025 | |
| Harmony Biosciences LLC | $323.56 | 2023-2025 | Wakix |
| Amgen INC. | $302.19 | 2019-2022 | |
| Catalyst Pharmaceuticals, INC. | $295.54 | 2023-2025 | Fycompa |
| Sunovion Pharmaceuticals INC. | $281.78 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $266.10 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $258.42 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $218.88 | 2022 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.